Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Mesoblast Limited (MESO)

  • Business News
  • Aug. 07, 2026, 07:02 UTC
  • 0
  • 1 comments

Ceasing to be a substantial holder

Market reaction Comment Full text

AFRICA ISRAEL RESIDENCES LTD. (AFRE)

  • Business News
  • Aug. 07, 2026, 06:42 UTC
  • 0
  • 1 comments

Granting validity to the Aba Hillel project in Ramat Gan

Market reaction Comment Full text

FIRST INDUSTRIAL REALTY TRUST INC (FR)

  • Business News
  • Aug. 07, 2026, 06:32 UTC
  • 0
  • 1 comments

EXERCISE OF MAKE-WHOLE REDEMPTION OPTION

Market reaction Comment Full text

FIRST INDUSTRIAL REALTY TRUST INC (FR)

  • Business News
  • Aug. 07, 2026, 06:32 UTC
  • 0
  • 1 comments

EXERCICE D’OPTION DE REMBOURSEMENT ANTICIPÉ (MAKE-WHOLE REDEMPTION)

Market reaction Comment Full text

NEXT VISION STABILIZED SYSTEMS (NXSN)

  • Business News
  • Aug. 07, 2026, 06:20 UTC
  • 0
  • 1 comments

Receipt of purchase orders

Market reaction Comment Full text

NEXT VISION STABILIZED SYSTEMS (NXSN)

  • Business News
  • Aug. 07, 2026, 06:20 UTC
  • 0
  • 1 comments

Orders for the purchase of cameras and additional products for a total of approximately $14.4 million, for delivery by the end of Q4/26

Market reaction Comment Full text

EL AL ISRAEL AIRLINES LTD. (ELAL)

  • Business News
  • Aug. 07, 2026, 06:17 UTC
  • 0
  • 1 comments

Shareholders registry, changes and share capital status - exercise of employee warrants

Market reaction Comment Full text

DORAL GROUP RENEWABLE ENERGY RESOURCES LTD (DORL)

  • Business News
  • Aug. 07, 2026, 06:08 UTC
  • 2
  • 1 comments

Became an interested party - The Phoenix Investment House Ltd.

Market reaction Comment Full text

DORAL GROUP RENEWABLE ENERGY RESOURCES LTD (DORL)

  • Business News
  • Aug. 07, 2026, 06:07 UTC
  • 0
  • 1 comments

Became an interested party – Harel Phoenix Financials Ltd.

Market reaction Comment Full text

BITWISE AVALANCHE ETF (BAVA)

  • Business News
  • Aug. 07, 2026, 06:00 UTC
  • 0
  • 1 comments

Bavarian Nordic Receives European Commission Approval of Mpox/Smallpox Vaccine for Children Aged 2 to Less than 12 Years

Market reaction Comment Full text
  • Previous
  • 421
  • 422
  • 423
  • 424
  • 425
  • Next

Search

News categories

  • Technical Exchange News(14257)
  • Event(6229)
  • SEC News(367107)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(225831)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin